A61K 31/415
1,2-diazoles
Official title: 1,2-Diazoles
A61K31/415 (1,2-diazoles) appears on 4,467 US grants and 6,350 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,467
- Published applications
- 6,350
- Assignees
- 2,415
- Inventors
- 14,376
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 24 | 0 |
| 1977 | 15 | 0 |
| 1978 | 28 | 0 |
| 1979 | 26 | 0 |
| 1980 | 32 | 0 |
| 1981 | 30 | 0 |
| 1982 | 22 | 0 |
| 1983 | 15 | 0 |
| 1984 | 18 | 0 |
| 1985 | 20 | 0 |
| 1986 | 22 | 0 |
| 1987 | 30 | 0 |
| 1988 | 34 | 0 |
| 1989 | 27 | 0 |
| 1990 | 46 | 0 |
| 1991 | 39 | 0 |
| 1992 | 71 | 0 |
| 1993 | 84 | 0 |
| 1994 | 64 | 0 |
| 1995 | 64 | 0 |
| 1996 | 88 | 0 |
| 1997 | 133 | 0 |
| 1998 | 82 | 0 |
| 1999 | 80 | 0 |
| 2000 | 71 | 0 |
| 2001 | 75 | 18 |
| 2002 | 77 | 129 |
| 2003 | 61 | 189 |
| 2004 | 43 | 238 |
| 2005 | 63 | 182 |
| 2006 | 60 | 151 |
| 2007 | 41 | 142 |
| 2008 | 44 | 153 |
| 2009 | 38 | 176 |
| 2010 | 79 | 200 |
| 2011 | 84 | 204 |
| 2012 | 97 | 202 |
| 2013 | 135 | 260 |
| 2014 | 188 | 304 |
| 2015 | 216 | 345 |
| 2016 | 214 | 347 |
| 2017 | 253 | 315 |
| 2018 | 228 | 326 |
| 2019 | 205 | 305 |
| 2020 | 219 | 310 |
| 2021 | 183 | 324 |
| 2022 | 153 | 341 |
| 2023 | 142 | 279 |
| 2024 | 147 | 322 |
| 2025 | 154 | 314 |
| 2026 | 103 | 274 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Stable pharmaceutical compositions of edaravone and dextrocamphol6 Oct 2026US 12,751,941 B2Jiangsu Simcere Pharmaceutical Co., Ltd.
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Use of composition containing cilostazol in cerebrovascular diseases29 Sep 2026US 12,746,234 B2Neurodawn Pharmaceutical Co., Ltd.
- Compositions and methods comprising endothelin a receptor antagonists and androgen therapies29 Sep 2026US 12,746,239 B2The United States Government as represented by the Department of Veterans Affairs
- Combination therapies of FASN inhibitors with thyroid hormone receptor agonists29 Sep 2026US 12,746,242 B2Sagimet Biosciences Inc.
- Use of small molecules to increase hypoxia inducible factor (hif) activity8 Oct 2026US 2026/0306440 A1Brown University
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Composition, methods and uses8 Oct 2026US 2026/0306509 A14E Therapeutics, Inc.
- Prodrugs of myc inhibitors8 Oct 2026US 2026/0308129 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof1 Oct 2026US 2026/0294884 A1Insilico Medicine IP Limited
Most cited
By later US patents
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992
- Therapeutic system for administering clonidine transdermally335US 4,201,211 AAlza Corporation · 1980
- Derivatives of N-phenylpyrazoles191US 5,232,940 A1993
- Automatic injector for emergency treatment183US 4,795,433 ASurvival Technology, Inc. · 1989
- Pharmaceutical formulations of acid labile substances for oral use181US 4,853,230 AAktiebolaget Hassle · 1989